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TO THE EDITOR
We read with great interest the recent
paper by Jiang et al. (2011). The authors
performed a meta-analysis of 15 case–-
control studies involving 6,362 subjects
to examine the association between the
TP53 Arg72Pro polymorphism and skin
cancer risk. The meta-analysis suggests
that the TP53 Arg72Pro polymorphism
may have little involvement in skin
cancer susceptibility. Nevertheless, I
have several concerns.
First, they concluded that the TP53
Arg72Pro polymorphism may have little
involvement in the pathogenesis of skin
cancer, regardless of type, including
melanoma, squamous cell carcinoma
(SCC), and basal cell carcinoma (BCC).
But their results are insufficient to
support the conclusion. In the meta-
analysis, only 3 (348 cases and 730
controls) of the 15 studies were con-
ducted in non-Caucasians. In addition,
although they did not observe the
association between the TP53 Arg72Pro
polymorphism and risk of melanoma,
SCC, and BCC in the subgroup analysis
according to subtypes of skin cancer,
the results may be unreliable owing
to the limited sample size (melanoma:
1,282 cases and 2,149 controls; SCC:
670 cases and 1,635 controls; BCC:
804 cases and 1,891 controls). There-
fore, the results of the meta-analysis
indicate that the TP53 Arg72Pro
polymorphism may have little involve-
ment in the pathogenesis of skin
cancer, mainly in Caucasians. Further
studies based on larger sample size
and stratified by subtypes of skin cancer
are still needed, especially in non-
Caucasians.
Second, there are some problems
with the methods. A meta-analysis
should encompass as much infor-
mation as possible. However, the
authors searched only for articles in
the Medline database using the
PubMed engine, and results were lim-
ited to papers published in the English
language. Hence, it is possible that
some studies that meet the inclusion
criteria were not included in the meta-
analysis. Database bias, language bias,
and publication bias may have distorted
the results of the meta-analysis. In
addition, although the genotype con-
trasts (Arg/Arg versus Pro/Pro, Arg/Pro
versus Pro/Pro, Arg/ArgþArg/Pro
versus Pro/Pro, Arg/Arg versus Arg/
Proþ Pro/Pro) were reported in the
article, the allele (Arg allele versus Pro
allele) contrast was not reported. It is
necessary to perform the allele contrast.
Finally, they should follow PRISMA
(Preferred Reporting Items for
Systematic Reviews and Meta-Analyses)
guidelines when reporting their
meta-methods research (Liberati et al.,
2009).
Third, the article has other short-
comings. The quality of the studies
in the meta-analysis was assessed
using the predefined scale for quality
assessment (Table 5 in the article).
But their quality scale omitted the
important factor of whether cases and
controls were matched by age and
gender. Lack of matching by age and
gender could result in bias in case–-
control studies. Also, to determine the
sources of the heterogeneity across
studies, the authors performed the
stratified analysis by subtypes of skin
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cancer (melanoma, SCC, and BCC).
However, although all the studies on
melanomas were conducted in Cauca-
sians and classified as high quality,
significant between-study heterogeneity
was still detected in melanomas sub-
group (Table 4 in the article). A more
precise analysis stratified by grade of
melanoma, SCC, and BCC may be
helpful to reach a more definitive
conclusion (of course, unknown factors
may account for the heterogeneity). In
addition, the authors’ Table 2 shows
that 15 case–control studies encom-
passed 6,363 subjects (2,861 cases
and 3,502 controls), but Table 3 lists
the total sample size of 15 case–control
studies as 6,362 (2,860 cases and 3,502
controls).
Overall, the meta-analysis suggests
that the TP53 Arg72Pro polymorphism
may have little involvement in the
pathogenesis of skin cancer, mainly in
Caucasians. Additional studies in larger
sample sizes and stratified by subtype of
skin cancer are still needed, especially
in non-Caucasians. Meanwhile, we
believe that our remarks will contribute
to more accurate elaboration and sub-
stantiation of the results presented by
Jiang et al. (2010).
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TO THE EDITOR
Pseudoxanthoma elasticum (PXE) is an
autosomal recessive disorder character-
ized by ectopic mineralization of soft
connective tissues (Li et al., 2009a;
Uitto et al., 2010). The clinical mani-
festations derive primarily from the
involvement of three organ systems,
the skin, the eyes, and the cardiovas-
cular system. There is considerable
phenotypic, both intra- and inter-
familial, heterogeneity with respect to
the age of onset and the severity of the
disease. Furthermore, in some families
the involvement of one of the organ
systems predominates, so that in some
families the primary manifestations are
in the skin with little eye or cardiovas-
cular involvement, whereas in others,
the ocular problems are the major
cause of morbidity. The eye manifesta-
tions characteristically consist of
angioid streaks that are due to miner-
alization of an elastin-rich Bruch’s
membrane behind the pigmented retina
(Booij et al., 2010). Mineralization of
this membrane causes ruptures of blood
vessels with subsequent neovasculari-
zation, associated with bleeding to
the eye, and leading to progressive loss
of visual acuity and, occasionally,
blindness.
Classic PXE is caused by mutations
in the ABCC6 gene, which encodes a
putative transmembrane transporter
protein, ABCC6, expressed primarily
in the baso-lateral surface of hepato-
cytes (Pfendner et al., 2007). ABCC6
has been shown in in vitro experiments
using inside–out insect cell vesicles to
function as an efflux pump, which
transports anionic small molecular
weight conjugates (Ilia´s et al., 2002).
However, the physiological ligands
in vivo and the precise role of ABCC6
in the pathomechanistic pathways
leading to peripheral connective tissue
mineralization are currently unknown.
Well over 300 distinct mutations
have been identified in the ABCC6
gene, consisting of premature termina-
tion codon (PTC)-causing mutations as
a result of nonsense mutations or out-
of-frame small insertions or deletions
(Pfendner et al., 2007). In addition,
large genomic deletions resulting in loss
of several exons or the entire gene,
and occasionally including flanking
genes as well, have been identified
(Chassaing et al., 2007). Finally, a
number of missense mutations, particu-
larly those affecting the nucleotide
binding folds (NBF1 and NBF2), two
protein domains critical for the function
of ABCC6 as a transmembrane trans-
porter protein, have been identified.
Careful examination of the mutation
database in the context of phenotypic
variability in PXE has not revealed any
clear-cut genotype–phenotype correla-
tions (Pfendner et al., 2007). However,
specific mutations in ABCC6 have beenAbbreviations: PXE, pseudoxanthoma elasticum; PTC, premature termination codon
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